News Focus
News Focus
icon url

ManicTrader

02/20/12 1:36 AM

#196441 RE: ManicTrader #196440


16:47 CORT Corcept Therapeutics resumes trading about 43% higher at $4.32 on light volume following news that the FDA approved Korlym (see 16:20 posts) (3.03 +0.15)